Velocity Clinical Research in Blue Ash, Cincinnati, was established in 1988 by Dr. Gregory Gottschlich as New Horizons Clinical Research before being acquired by Velocity in 2017. Specializing in a wide range of medical indications, including respiratory, immunology, and orthopedics, the Cincinnati site conducts studies in vaccines and rare diseases with a diverse participant population.
With a commitment to quality research and patient care, the experienced team at Velocity Cincinnati, led by board-certified physicians like Dr. Matthew Wenker and Dr. Richard Powell, ensures all trials are conducted in compliance with ICH and FDA guidelines. The site's convenient location, dedicated research space, and compassionate approach to advancing medicine through research make it a valuable resource for study volunteers and the community.
Generated from the website